5 Best Genomics Stocks To Buy Now

4. Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

Number of Hedge Fund Investors In Q3 2023: 29

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is an American firm that develops RNA based therapies. The firm was out with some great news in November 2023 when it shared that a trial of its sub surface skin swelling disease reduced attack rates by a strong 96%.

Insider Monkey scoured through 910 hedge funds for their investments during 2023’s September quarter to discover that 29 had bought the firm’s shares. Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)’s biggest hedge fund investor is Mark Lampert’s Biotechnology Value Fund / BVF Inc as it owns $181 million worth of shares.

Follow Ionis Pharmaceuticals Inc (NASDAQ:IONS)